APA (7th ed.) Citation

Subrahmanyam, P. B., Dong, Z., Gusenleitner, D., Giobbie-Hurder, A., Severgnini, M., Zhou, J., . . . Hodi, F. S. (2018). Distinct predictive biomarker candidates for response to anti-CTLA-4 and anti-PD-1 immunotherapy in melanoma patients. Journal for immunotherapy of cancer, 6(1), 18-14. https://doi.org/10.1186/s40425-018-0328-8

Chicago Style (17th ed.) Citation

Subrahmanyam, Priyanka B., et al. "Distinct Predictive Biomarker Candidates for Response to Anti-CTLA-4 and Anti-PD-1 Immunotherapy in Melanoma Patients." Journal for Immunotherapy of Cancer 6, no. 1 (2018): 18-14. https://doi.org/10.1186/s40425-018-0328-8.

MLA (9th ed.) Citation

Subrahmanyam, Priyanka B., et al. "Distinct Predictive Biomarker Candidates for Response to Anti-CTLA-4 and Anti-PD-1 Immunotherapy in Melanoma Patients." Journal for Immunotherapy of Cancer, vol. 6, no. 1, 2018, pp. 18-14, https://doi.org/10.1186/s40425-018-0328-8.